How should cost data in pragmatic randomised trials be analysed?

Pragmatic randomised trials are usually large scale multicentre studies in which interventions or medical policies are compared in a realistic setting.1 The intention is that conclusions from these trials, if accepted, can be adopted directly into medical practice.2 Economic evaluations carried out alongside these trials are increasingly common because it is often important to assess costs and cost effectiveness as well as clinical outcomes.3 Costs are usually derived from information about the quantity of healthcare resources used by each patient in the trial. The quantities of each resource used are multiplied by fixed unit cost values and are then summed over the separate types of resource to give a total cost per patient.4 Distribution of costs from a trial comparing endometrial resection with hysterectomy in women with menorrhagia. Costs are based on health resource use from randomisation to two years; they include preoperative, operative, hospital stay, complications, retreatment, and primary care components5 This information leads to a range of different costs across participants in the trial. As an example, the figure shows the distribution of costs in women with menorrhagia randomised to treatment with endometrial resection or abdominal hysterectomy.5 Such highly skewed distributions are typical of cost data; the long right hand tail reflects the fact that some patients incur high costs because of factors such as medical complications, reoperation, or extended hospital stay. ### Summary points Health economic evaluations are now commonly included in pragmatic clinical trials that inform policy decisions Despite the usual skewness in the distribution of costs, it is the arithmetic mean that is the most informative measure Measures other than the arithmetic mean do not provide information about the cost of treating all patients, which is needed as the basis for healthcare policy decisions Statistical analysis based on transforming cost data or …

[1]  S. Thompson,et al.  Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. , 2000, Statistics in medicine.

[2]  Sg Thompson,et al.  Analysis of cost data in randomised controlled trials: An application of the non-parametric bootstrap , 2000 .

[3]  A H Briggs,et al.  Handling uncertainty in economic evaluations of healthcare interventions , 1999, BMJ.

[4]  D. Torgerson,et al.  Randomised controlled trial of exercise for low back pain: clinical outcomes, costs, and preferences , 1999, BMJ.

[5]  J. Catalan,et al.  Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm , 1999, Psychological Medicine.

[6]  J. Forbes,et al.  Health service costs and quality of life for early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms , 1998, The Lancet.

[7]  S G Thompson,et al.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies , 1998, BMJ.

[8]  A Briggs,et al.  The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation , 1998, Journal of health services research & policy.

[9]  A. Gray,et al.  General practice Randomised controlled trial comparing hospital at home care with inpatient hospital care . I : three month follow up of health outcomes , 1998 .

[10]  I. Marks,et al.  Home-based versus hospital-based care for serious mental illness , 1998, British Journal of Psychiatry.

[11]  G. Nuki,et al.  Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation , 1998, BMJ.

[12]  P. Tyrer,et al.  Randomised controlled trial of two models of care for discharged psychiatric patients , 1998, BMJ.

[13]  P. Fayers,et al.  Generalisation from phase III clinical trials: survival, quality of life, and health economics , 1997, The Lancet.

[14]  Bill Williams,et al.  Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial , 1997, BMJ.

[15]  A. Gray,et al.  Problems in conducting economic evaluations alongside clinical trials , 1997, British Journal of Psychiatry.

[16]  M. Sculpher,et al.  Randomised trial comparing hysterectomy and transcervical endometrial resection: effect on health related quality of life and costs two years after surgery , 1996, British journal of obstetrics and gynaecology.

[17]  D. Coyle Statistical analysis in pharmacoeconomic studies. A review of current issues and standards. , 1996, PharmacoEconomics.

[18]  E. van Doorslaer,et al.  Statistical analysis of cost outcomes in a randomized controlled clinical trial. , 1994, Health Economics.

[19]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[20]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .

[21]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[22]  M. Drummond,et al.  Economic analysis and clinical trials. , 1984, Controlled clinical trials.

[23]  M. Gardner,et al.  Statistical guidelines for contributors to medical journals. , 1983, British medical journal.

[24]  J. V. Bradley Distribution-Free Statistical Tests , 1968 .